AbbVie (NYSE:ABBV) Receives News Sentiment Score of 0.39

Insiders sold 278,135 shares of company stock valued at $18,841,085 in the last quarter. The fund owned 12,897 shares of the company's stock at the end of the first quarter. The company had a trading volume of 1,889,117 shares. The target gives a potential downside of -91.79 % from the last stock close price of Abbvie Inc (NYSE:ABBV). It has underperformed by 6.07% the S&P500.

HSN, Inc.is an interactive multi-channel retailer. The firm has a market capitalization of $115.96 billion, a price-to-earnings ratio of 18.89 and a beta of 1.51. The Firm markets and sells a range of third party and merchandise directly to clients through various platforms, including television home shopping programing broadcast on the HSN television networks and other direct-response television marketing; catalogs, consisting of the Cornerstone portfolio of print catalogs, which includes, Ballard Designs, Frontgate, Garnet Hill, Grandin Road and Improvements; Websites, which consist primarily of HSN.com, joymangano.com and the five branded Websites operated by Cornerstone; mobile devices; retail and outlet stores, and wholesale distribution of certain products to other retailers. It has a 22.42 P/E ratio. It operates through two divisions: HSN and Cornerstone. The firm earned "Buy" rating on Monday, December 7 by Jefferies. The company was maintained on Tuesday, January 26 by Deutsche Bank. The rating was upgraded by Citigroup on Tuesday, February 23 to "Buy". The ex-dividend date is Wednesday, July 12th. Atlantic Securities has "Neutral" rating and $59 target. The firm has "Buy" rating by Maxim Group given on Tuesday, November 8. Renaissance Macro Securities LLC maintained the shares of C in report on Sunday, July 16 with "Buy" rating.

Equities research analysts forecast that AbbVie Inc. will post $5.53 earnings per share for the current year. During the same period in the previous year, the business earned $1.15 earnings per share. LNDC's profit will be $2.48M for 40.00 P/E if the $0.09 EPS becomes a reality. The company reported $1.28 EPS for the quarter, beating the Zacks' consensus estimate of $1.26 by $0.02.

Since February 28, 2017, it had 0 insider buys, and 10 sales for $28.02 million activity. 79,800 AbbVie Inc (NYSE:ABBV) shares with value of $5.59 million were sold by Schumacher Laura J. Shares for $3.21 million were sold by ALBAN CARLOS. The insider HURWICH THOMAS A. sold $143,031. 22,451 shares were sold by RICHMOND TIMOTHY J., worth $1.47M on Friday, March 10. Ltd. boosted its position in shares of AbbVie by 471.4% in the fourth quarter. It dropped, as 86 investors sold ABBV shares while 555 reduced holdings. 99 funds opened positions while 531 raised stakes. Kelly Lawrence W Associate Ca has 0.38% invested in AbbVie Inc (NYSE:ABBV). AbbVie Inc (NYSE:ABBV) has risen 10.63% since July 17, 2016 and is uptrending. Winslow Evans & Crocker Inc. raised its position in AbbVie by 9.6% in the second quarter. Montag A And Associate Incorporated owns 70,591 shares. Roosevelt Inv Group holds 0.04% or 6,985 shares in its portfolio. Marco Mngmt Lc owns 50,523 shares. Gideon Capital has 0.27% invested in AbbVie Inc (NYSE:ABBV) for 6,671 shares. Signalpoint Asset Limited Liability Corp accumulated 0.16% or 9,968 shares. Davis reported 31,075 shares. 320,123 are owned by Regions.

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company. Abbvie Inc has $9400 highest and $55 lowest target. Guardian Capital Lp stated it has 189,554 shares or 0.18% of all its holdings. Finally, Genovese Burford & Brothers Wealth & Retirement Plan Management LLC increased its stake in shares of AbbVie by 5,766.3% in the fourth quarter. Dex Inc (NASDAQ:DXCM) was raised too. Therefore 39% are positive. Abbvie Inc had 40 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, June 10, the company rating was downgraded by BMO Capital Markets. SunTrust has "Buy" rating and $4.0 target. The firm has "Hold" rating by Credit Suisse given on Wednesday, June 7. Investors of record on Friday, July 14th will be given a $0.64 dividend. Stephens Ar invested 0.75% of its portfolio in AbbVie Inc (NYSE:ABBV). On Monday, June 6 the stock rating was downgraded by Cowen & Co to "Market Perform". Societe Generale upgraded AbbVie from a "sell" rating to a "hold" rating in a report on Wednesday, March 22nd.